Jill Remick

Papers

Total Citations

H-Index

About

Jill Remick is a leading voice in head and neck surgical oncology, with a focused expertise in oropharyngeal squamous cell carcinoma (OPSCC) and the comparative effectiveness of transoral robotic surgery (TORS) versus radiation therapy. Her work is distinguished by its reliance on real-world evidence, leveraging large national databases to validate and contextualize findings from clinical trials. Her landmark study, "Ninety‐day mortality following transoral robotic surgery or radiation at Commission on Cancer‐accredited facilities," analyzed over 4,000 patients from the National Cancer Database and demonstrated that TORS is associated with significantly lower 90-day mortality than primary radiation in low-risk patients. This contribution is critical for shared decision-making, providing surgeons and patients with robust, population-level data on postoperative outcomes. With over 6 citations and growing, this paper has become a cornerstone reference for treatment de-escalation strategies. Remick’s research bridges the gap between trial efficacy and real-world effectiveness, making her a pivotal figure in shaping modern, evidence-based protocols for oropharynx cancer care.